G2019S LRRK2 ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 6 | パーキンソン病 | 1 |
6. パーキンソン病
臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04919356 (ClinicalTrials.gov) | June 8, 2021 | 4/6/2021 | Parkinson's Disease G2019S LRRK2 Genetic Testing Program | G2019S LRRK2 Parkinson's Disease: Increasing Awareness and Genetic Testing Program | Parkinson's Disease | Genetic: G2019S LRRK2 | Escape Bio, Inc. | Engage Health Inc.;Sano | Terminated | 18 Years | N/A | All | 836 | United States |